PDCD1 and neoplasm: The manufactured CAR-T cells express low levels of exhaustion or inhibitory checkpoint molecules like PD-1, TIM-3, and LAG-3 confirming less susceptibility for inhibitory signals from tumor cells and validating their non-exhausted and high functional phenotype.